News Archive
U-M spinoff biopharmaceutical company Lycera to move into North Campus Research Complex
June 8, 2011
Lycera Highlights Bioenergetics and RORγt Programs at Industry Conferences
March 27, 2011
Lycera Announces Research Collaboration with Merck to Discover, Develop and Commercialize Drugs for Autoimmune Diseases
March 3, 2011
Data Published in Science Translational Medicine Point to Role of Cellular Bioenergetics as
a New Mechanistic Approach to Treat Immune Disorders
January 26, 2011
Lycera Achieves $11 Million Second Tranche in Series A Financing
April 28, 2010
Lycera Appoints Senior Life Sciences Executive William J. Sibold as President and CEO
January 7, 2010
Lycera Appoints Key Executives To Drug Development Team
October 9, 2009
Lycera Adds Accomplished Scientists to Scientific Advisory Board
August 18, 2009
Lycera Adds Prominent Pharmaceutical Scientist and Executive to Board
July 29, 2009
Lycera Closes $36 M Series A Financing
April 16, 2009
